ID Biomedical shares reach new 52-week high on hopes for business next year

VANCOUVER (CP) - Shares of ID Biomedical reached a new high Monday as investors and analysts cheered news that the company was on track to start selling its flu vaccine in the United States starting next year. ID Biomedical shares (TSX:IDB) added $2.05, or 7....More